Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Organic Health Response | OTHER |
| Microclinic International | OTHER |
| Kenya Medical Research Institute | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This pilot study is a non-randomized controlled cohort study evaluating the impact of social network-based HIV education on antiretroviral therapy (ART) adherence, clinical outcomes, food security, social support, HIV knowledge, and risk behaviors among people living with HIV/AIDS, as well as members of their associated social support networks. The intervention, known as the Mfangano Health Net Microclinic Pilot Program, consists of a 6-month education program on HIV biology, interpersonal communication and community mobilization for both HIV positive individuals and their self-selected social network members selected irrespective of HIV status. Investigators hypothesize that participation in the microclinic program will improve ART adherence, cluster of differentiation 4 (CD4) count, social support, HIV knowledge and food insecurity and will reduce HIV-related stigma, as compared to participants in control communities.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Intervention | Experimental | This arm is eligible for participation in the Mfangano Health Net Microclinic Program, a social network-based educational program. |
|
| Comparison | No Intervention | This arm is not eligible for participation in the intervention. Participants still have access to usual care at the Sena Health Center or their health facility of choice. |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Mfangano Health Net Microclinic Program | Behavioral | Educational program in which HIV positive individuals are invited to recruit their social networks to form 'microclinic' groups. These groups participate in a 6-month educational curriculum composed of information on HIV biology, interpersonal communication strategies and community mobilization. At the conclusion of the program, participants are encouraged to disclose their HIV status to members of their group through a facilitated disclosure process. |
| Measure | Description | Time Frame |
|---|---|---|
| Antiretroviral therapy (ART) Adherence | change in ART drug levels measured in small hair samples from baseline to 6 months | change from baseline to 6-months |
| Disengagement from care | Incidence of missing a clinic appointment by ≥90 days without having first transferred care to another clinic or died. | From time of study enrollment to first instance of 90-day gap in care, censorship (death, transfer outside study area) or end of study (up to 22 months) |
| Measure | Description | Time Frame |
|---|---|---|
| Stigma | stigma as measured by Parallel HIV/AIDS Stigma Scale (Attributed Stigma Attitudes) | change from baseline to 6-months |
| Social support | Social support as measured by Duke-University of North Carolina (UNC) Functional Social Support Scale |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Craig R Cohen, MD | University of California, San Francisco | Principal Investigator |
| Elizabeth Bukusi, MBChB, M.Med | Kenya Medical Research Institute | Principal Investigator |
| Charles R Salmen, MSc, MD Candidate | University of California, San Francisco | Principal Investigator |
| Matthew D Hickey, MD Candidate | University of California, San Francisco | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Ekialo Kiona Center | Kitawi Beach, Mfangano Island | Nyanza | Kenya |
Not provided
| ID | Term |
|---|---|
| D057545 | Social Stigma |
| ID | Term |
|---|---|
| D012919 | Social Behavior |
| D001519 | Behavior |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| change from baseline to 6-months |
| HIV knowledge | HIV knowledge as measured by HIV Knowledge Questionnaire ("HIV-KQ-18") | change from baseline to 6-months |
| Time in care | Proportion of time eligible for HIV care that patient is adherent to clinic appointment schedules. Calculated by subtracting the sum of all gaps in care from the total time eligible for care, and dividing by total time eligible for care. Gaps in care are defined as the number of days between a missed appointment and subsequent return to any clinic in the study area to access HIV care. | From time of study enrollment until study closure (22 months) or censorship (death or transfer of care to facility outside study area) |
| ART adherence - end of study | change in ART drug levels measured in small hair samples from baseline to end of study | change from baseline to end of study (22 months) |